LOS ANGELES, CA--(Marketwire -06/04/12)- The ZYPPAH hybrid oral appliance (OA) provides a new way for the medical and dental communities to treat snoring, which affects 90 million Americans, and sleep apnea, which affects an estimated 18 million Americans, according to the National Sleep Foundation. Developed by Dr. Jonathan Greenburg, a biomedical engineer and dentist who has studied sleep apnea and snoring since 2001, the ZYPPAH has been tested in his five Snore No More sleep centers for the past five years. The ZYPPAH allows the individual to sleep in any position, fits comfortably inside the mouth and holds the tongue in place, making it a more effective, easy-to-use solution than anything on the market. Pronounced "Zee Pah," the easiest way to remember ZYPPAH is that it is "Happy Z" spelled backwards.
The differentiating factor that makes ZYPPAH superior to, and more effective than, other snoring devices on the market is that it combines two treatments: the mandibular advancement (moving the jaw forward) and stabilization of the tongue. When combined, these actions prevent the tongue from obstructing the airflow, the primary cause of snoring. Greenburg has conducted clinical pre- and post-sleep studies that show significant improvement in the quality of patients' sleep and their ability to perform after using the ZYPPAH.
"When I stopped practicing dentistry and started focusing on helping people with their snoring and sleep apnea, I received a new type of appreciation from patients who tell me I've changed their lives," says Greenburg. "Having this kind of impact on the quality of people's lives and knowing that my work could help prolong their lives is phenomenal."
A consumer version of the ZYPPAH is now available to reduce snoring, and a more robust version is available for doctors and dentists to prescribe for sleep apnea. The professional version of the ZYPPAH has a wide elastic band and four adjustment settings to allow increased advancement of the jaw based on the level of sleep apnea. The consumer version, for snoring only, has a slim elastic band and is not adjustable.
Until now, most patients diagnosed with obstructive sleep apnea (OSA) have been treated with a continuous positive airway pressure (CPAP) machine, surgery or an oral appliance. Although the CPAP is highly effective, many people refuse to use it because the CPAP mask is bulky, forces one to sleep on one's back and is often considered unattractive. Oral appliances, such as the ZYPPAH, have become the new standard in the treatment of snoring and sleep apnea.
Snoring can be an indicator of sleep apnea, which has been linked to cancer, heart disease and stroke. According to a study published recently in the American Journal of Respiratory and Critical Care Medicine, snoring and "sleep disordered breathing is associated with increased cancer mortality." Based on data examined from the 22-year-long "Sleep Apnea and Cancer Mortality" study conducted by the University of Wisconsin School of Medicine and Public Health, people with severe sleep apnea died of cancer at 4.8 times the rate than did those without the disorder. Even those with moderate sleep apnea were found to die of cancer at twice the rate of people without sleep disordered breathing.
Purchase the ZYPPAH consumer appliance before June 14, in time for Father's Day, for a special price of $72 (Regularly $123). For more information or to receive a free snoring and sleep apnea e-guide, visit www.zyppah.com or call (800) 8-SLEEP-0 or (800) 875-3370.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2001447